ConductScience.org, home
Papers
API referenceFor AI assistants

Paper · 36263299

Triglyceride to high-density lipoprotein cholesterol ratio and total cholesterol to high-density lipoprotein cholesterol ratio and risk of benign prostatic hyperplasia in Chinese male subjects.

Zhu C and 8 others. Front Nutr, 2022. Cited by 13 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Triglyceride to high-density lipoprotein cholesterol ratio and total cholesterol to high-density lipoprotein cholesterol ratio and risk of benign prostatic hyperplasia in Chinese male subjects. Papers, record 36263299. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36263299

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Triglyceride to high-density lipoprotein cholesterol ratio and total cholesterol to high-density lipoprotein cholesterol ratio and risk of benign prostatic hyperplasia in Chinese male subjects.
PubMed
Journal
Front Nutr
PubMed
Year
2022
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
13
iCite
Relative citation ratio, by iCite
1.33
iCite
Revised in PubMed
2022-10-21
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Zhu CChen
2Wu JJuan
3Wu YYixian
4Guo WWen
5Lu JJing
6Zhu WWenfang
7Li XXiaona
8Xu NNianzhen
9Zhang QQun

Source PubMed

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References31

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
131,325,411Higher triglyceride to high-density lipoprotein cholesterol ratio increases cardiovascular risk: 10-year prospective study in a cohort of Chinese adults.J Diabetes Investig2020https://conductscience.org/library/papers/31325411PubMed
228,332,908The association between triglyceride high density lipoprotein cholesterol ratio and benign prostate hyperplasia in non-diabetic patients:a cross-sectional study.Aging Male2017https://conductscience.org/library/papers/28332908PubMed
333,969,127Association of the Ratio of Triglycerides to High-Density Lipoprotein Cholesterol Levels with the Risk of Type 2 Diabetes: A Retrospective Cohort Study in Beijing.J Diabetes Res2021https://conductscience.org/library/papers/33969127PubMed
424,246,728Association of metabolic syndrome and benign prostatic hyperplasia in Chinese patients of different age decades.Urol Int2014https://conductscience.org/library/papers/24246728PubMed
533,588,849
Triglycerides to high-density lipoprotein cholesterol ratio is superior to triglycerides and other lipid ratios as an indicator of increased urinary albumin-to-creatinine ratio in the general population of China: a cross-sectional study.
Lipids Health Dis2021https://conductscience.org/library/papers/33588849PubMed
634,727,357Aging tsunami coming: the main finding from China's seventh national population census.Aging Clin Exp Res2022https://conductscience.org/library/papers/34727357PubMed
733,593,479Current Treatment for Benign Prostatic Hyperplasia.Dtsch Arztebl Int2020https://conductscience.org/library/papers/33593479PubMed
832,131,838Association of Triglyceride to high-density lipoprotein cholesterol ratio and incident of diabetes mellitus: a secondary retrospective analysis based on a Chinese cohort study.Lipids Health Dis2020https://conductscience.org/library/papers/32131838PubMed
924,602,293Metabolic syndrome and benign prostatic enlargement: a systematic review and meta-analysis.BJU Int2015https://conductscience.org/library/papers/24602293PubMed
1028,823,197Visceral adiposity index is associated with benign prostatic enlargement in non-diabetic patients: a cross-sectional study.Aging Male2018https://conductscience.org/library/papers/28823197PubMed

1 to 10 of 31

See all 31 references

Cited by10

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 13 citations.

PMIDTitleJournalYearIn PapersSource
42,643,683Prospective Metabolomic Cohort of 123,037 Men Reveals Lipid Mediators Linking Air Pollution to Benign Prostatic Hyperplasia.Environ Health (Wash)2026https://conductscience.org/library/papers/42643683PubMed
42,538,422Effects of tadalafil on endothelial, angiogenic, metabolic, and microRNA biomarker profiles in sexually active men with BPH and erectile dysfunction: a randomized controlled trial.Naunyn Schmiedebergs Arch Pharmacol2026https://conductscience.org/library/papers/42538422PubMed
42,022,904The triglyceride-to-HDL cholesterol ratio is associated with lower BMD in older adults at high altitudes: a retrospective retrospective cross sectional study.Front Endocrinol (Lausanne)2026https://conductscience.org/library/papers/42022904PubMed
41,029,140A Mendelian randomization study between air pollutants and benign prostatic hyperplasia.Medicine (Baltimore)2025https://conductscience.org/library/papers/41029140PubMed
40,849,494
Association between the non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio (NHHR) and early-onset benign prostatic hyperplasia: a cross-sectional analysis based on NHANES.
J Health Popul Nutr2025https://conductscience.org/library/papers/40849494PubMed
40,527,838Non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio in relation to benign prostatic hyperplasia: A cross-sectional study.Medicine (Baltimore)2025https://conductscience.org/library/papers/40527838PubMed
39,615,445Management of a patient of hypertriglyceridemia with Benign Prostate Hyperplasia through integrative medicine - A case report.J Ayurveda Integr Med2024https://conductscience.org/library/papers/39615445PubMed
38,628,856Awareness and prevalence of self-reported benign prostatic hyperplasia: a cross-sectional study in Saudi Arabia.Front Public Health2024https://conductscience.org/library/papers/38628856PubMed
38,001,725Unveiling Disrupted Lipid Metabolism in Benign Prostate Hyperplasia, Prostate Cancer, and Metastatic Patients: Insights from a Colombian Nested Case-Control Study.Cancers (Basel)2023https://conductscience.org/library/papers/38001725PubMed
37,564,954Association Between Mean Platelet Volume and Benign Prostatic Hyperplasia: A Population Study from the TCLSIH Cohort Study.J Inflamm Res2023https://conductscience.org/library/papers/37564954PubMed

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
KLK3354PubTator's text mininghttps://conductscience.org/library/genes/354

Source NCBI Gene

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36263299

GET https://conductscience.org/api/papers/v1/36263299/references?page=2

API referenceFor AI assistants